Nomlabofusp

· Larimar Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nomlabofusp, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia [Phase 1]